In the news

05.06.2023

Visgenx Appoints William Pedranti as Chief Executive Officer

»

24.05.2023

Attending BIO 2023? Click below to send Visgenx a meeting request in the...

»

15.05.2023

Visgenx to present at the American Society of Gene and Cell Therapy...

»

Reversal in Focus.

We aim to “turn back the clock” to a more youthful level of ELOVL2 expression.